62
In band
Moving averages
SMA 200$4.74+55.06%
Company profile
ATAI Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany.
SectorHealthcare
IndustryBiotechnology
Market cap$2.73B
P/E ratioNone
EPS$-2.79
Beta1.552
52-week high$7.45
52-week low$3.27
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 54
AUPH
Aurinia Pharmaceuticals Inc
RSI 49
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
TARS
Tarsus Pharmaceuticals Inc
RSI 55
VKTX
Viking Therapeutics Inc
RSI 48
NVAX
Novavax Inc
RSI 45
RSI alerts for ATAI
An email when ATAI closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 10:12 PM EDT